低血糖与2型糖尿病合并冠心病患者高敏肌钙蛋白T升高的关联
基于BARI 2D试验中1984例2型糖尿病合并稳定性冠心病患者,第一年随访低血糖发生情况,并在基线和1年时测定高敏肌钙蛋白T(hsTnT)。低血糖与hsTnT升高相关,但校正糖尿病病程和严重程度后关联减弱,提示可能反映更严重的糖尿病而非低血糖直接导致。
要点
- 严重低血糖与1年hsTnT升高相关,但校正糖尿病相关因素后关联不再显著。
- 低血糖频率≥每周也与hsTnT升高相关,校正糖尿病因素后关联减弱。
- 临床需关注低血糖患者的糖尿病严重程度,其可能是hsTnT升高的主要驱动因素。
核心结论
- 低血糖与hsTnT水平升高相关,但此关联可能源于发生低血糖患者更严重的糖尿病,而非低血糖的直接结果。
研究设计与样本
- BARI 2D随机试验纳入1984例2型糖尿病合并稳定性冠心病患者,第一年密切随访低血糖,基线和1年测定hsTnT,采用多变量回归分析。
主要发现
- 随访期间无低血糖1026例(52%),轻度875例(44%),严重83例(4%);低血糖频率<每周561例(28%),≥每周397例(20%)。
- hsTnT中位数:无低血糖11.4 ng/l(IQR 8.1-17.3),轻度12.5 ng/l(IQR 8.3-19.3),严重13.7 ng/l(IQR 9.9-24.9),p=0.0001。
- hsTnT中位数:低血糖<每周12.5 ng/l(IQR 8.3-18.1),≥每周13.0 ng/l(IQR 8.8-21.1),p=0.0013。
- 严重低血糖与1年hsTnT升高34%(未校正,p<0.0001)、17%(校正非糖尿病基线因素后,p=0.006)、6%(进一步校正糖尿病病程和严重程度后,p=0.23)相关。
- 低血糖≥每周与hsTnT升高14%(未校正,p=0.0003)、12%(校正非糖尿病基线因素后,p=0.0002)、4%(校正糖尿病相关因素后,p=0.16)相关。
临床怎么用
- 对糖尿病合并冠心病患者,出现低血糖时应评估糖尿病严重程度及心肌损伤风险。
- hsTnT升高不能简单归因于低血糖,需结合糖尿病病程和严重程度综合解读。
局限性
- 低血糖与hsTnT的关联在校正糖尿病相关因素后减弱,提示可能存在残余混杂。
- 研究为观察性分析,不能确立低血糖与心肌损伤的因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Diabetic medications can cause hypoglycemia, which may lead to myocardial damage. OBJECTIVES: This study sought to determine whether hypoglycemia is associated with higher levels of high-sensitivity cardiac troponin T (hsTnT). METHODS: The BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial randomized patients with type 2 diabetes mellitus and stable coronary artery disease, and closely followed them for hypoglycemia over the first year. Hypoglycemia was classified by maximum severity and frequency. hsTnT was measured at baseline and 1 year, and analyzed using multivariable regression. RESULTS: Of 1,984 patients, follow-up hypoglycemia was absent in 1,026 (52%) patients, mild in 875 (44%), and severe in 83 (4%), and occurred less than weekly in 561 (28%) and greater than or equal to weekly in 397 (20%). hsTnT levels were associated with hypoglycemia: a median of 11.4 ng/l (interquartile range [IQR]: 8.1 to 17.3 ng/l) for none, 12.5 ng/l (IQR: 8.3 to 19.3 ng/l) for mild, and 13.7 ng/l (IQR: 9.9 to 24.9 ng/l) for severe hypoglycemia (p = 0.0001); and 12.5 ng/l (IQR: 8.3 to 18.1 ng/l) for less than weekly and 13.0 ng/l (IQR: 8.8 to 21.1 ng/l) for greater than or equal to weekly hypoglycemia (p = 0.0013). Severe hypoglycemia was associated with 34% higher 1-year hsTnT levels (p < 0.0001) in unadjusted analysis, 17% higher (p = 0.006) after adjustment for baseline factors unrelated to diabetes, and 6% higher (p = 0.23) after further adjustment for the duration and severity of diabetes. Hypoglycemia greater than or equal to weekly was associated with 14% higher hsTnT (p = 0.0003) in unadjusted analysis, 12% higher (p = 0.0002) after adjustment for baseline factors unrelated to diabetes, and 4% higher (p = 0.16) after adjustment for diabetes related factors. CONCLUSIONS: Hypoglycemia was associated with elevated hsTnT levels, but this may be due to more severe diabetes in patients who developed hypoglycemia, rather than the direct result of hypoglycemia. (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes [BARI2D]; NCT00006305).
引用
- Rezende PC, Everett BM, Brooks MM, et al. Hypoglycemia and Elevated Troponin in Patients With Diabetes and Coronary Artery Disease. J Am Coll Cardiol. 2018. PMID: 30286920. doi:10.1016/j.jacc.2018.07.067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。